2020
DOI: 10.1007/s00216-020-02933-w
|View full text |Cite
|
Sign up to set email alerts
|

Exercise-induced recovery of plasma lipids perturbed by ageing with nanoflow UHPLC-ESI-MS/MS

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
3
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 48 publications
1
3
0
Order By: Relevance
“…In the present study, exercise training reduced several ceramide and sphingomyelin species, and dihydrosphingomyelins. This finding is consistent with previous research showing that exercise reduced plasma ceramide (c14:0) in obese and diabetic subjects ( 89 ) and in mice ( 90 ). Exercise training also decreased sphingosines and sphingolipid synthesis metabolites.…”
Section: Discussionsupporting
confidence: 93%
“…In the present study, exercise training reduced several ceramide and sphingomyelin species, and dihydrosphingomyelins. This finding is consistent with previous research showing that exercise reduced plasma ceramide (c14:0) in obese and diabetic subjects ( 89 ) and in mice ( 90 ). Exercise training also decreased sphingosines and sphingolipid synthesis metabolites.…”
Section: Discussionsupporting
confidence: 93%
“…Moderate CR can be used to halt the age- related kidney dysfunction by inhibiting the endothelin-1 (ET-1) expression [68]. In aged mice, physical exercise reduces triacylglycerol and restores plasma lipids homeostasis by regulating lipid metabolism [70]. Dehydroascorbic acid (DHA) retards or even reverses renal impairment in mouse models of ageing [71].…”
Section: Therapeutic Strategies For Kidney Ageingmentioning
confidence: 99%
“…Senolytics Dasatinib and quercetin [78], fisetin [79], catechins [80], uPAR-targeted CAR-T [58 && ], ABT263 [55], A1331852 [81], A1155463 [81], ABT737 [81], alvespimycin (17-DMAG) [76], FOXO4-DRI [56], panobinostat [82], BPTES [61 & ] Senostatics SS31 [83], klotho [62], mitoQ [84], SKQ1 [85], melatonin [86], ICG001 [45], Na 2 S 4 [43], ganoderma lucidum [87], ruxolitinib [75], MSC-derived EVs [64], SIRT1 activator [65], PPAR-g agonists [66], metformin [67], rapamycin [88] Nutrient regulators Calorie restriction [69,89], exercise [70], resveratrol [90], curcumin [91], spermidine [92], barbarum [93], DHA [71] DHA, dehydroascorbic acid; MSC, mesenchymal stem cells; PPAR-g, peroxisome proliferator-activated receptor-g; uPAR, urokinase-type plasminogen activator receptor.…”
Section: Senotherapy Agentsmentioning
confidence: 99%
“…Nevertheless, IMT decreased the serum levels of saturated lysophospholipid [LysoPC (16:0/0:0)] and lysophosphatidylethanolamine [LysoPE (18:0/0:0)]. Studies have shown that the serum elevation of these saturated fatty acids is associated with low-grade inflammation as a result of the aging process and metabolic disorders like insulin resistance, type 2 diabetes, and stroke [33][34][35]. In addition, Sphingosine 1-phosphate also decreased after IMT.…”
Section: Discussionmentioning
confidence: 99%